ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 133 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $302 | – | 10,716 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 362,459 | $15,727,096,000 | 18.11% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $115,609,000 | 2.54% |
| Matrix Capital Management Company, LP | 3,821,739 | $165,825,000 | 1.92% |
| Avidity Partners Management LP | 1,263,300 | $54,815,000 | 1.51% |
| Redmile Group, LLC | 2,221,044 | $96,371,000 | 1.36% |
| Affinity Asset Advisors, LLC | 77,500 | $3,363,000 | 1.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,140 | $7,599,000 | 0.58% |
| Eventide Asset Management | 832,000 | $36,100,000 | 0.54% |
| Integral Health Asset Management, LLC | 40,000 | $1,736,000 | 0.50% |
| VIKING GLOBAL INVESTORS LP | 2,399,284 | $104,105,000 | 0.31% |